MK-3475 and Hypofractionated Stereotactic Radiation Therapy in Patients With Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial ID NCT02444741

Rank	Title	Journal	Year	PubWeight™‹?›
1	Novel radiotherapy approaches for lung cancer: combining radiation therapy with targeted and immunotherapies.	Transl Lung Cancer Res	2015	0.99
2	Advances in immunotherapy for treatment of lung cancer.	Cancer Biol Med	2015	0.95
3	Strategies for combining immunotherapy with radiation for anticancer therapy.	Immunotherapy	2015	0.84
4	Trial Watch: Immunotherapy plus radiation therapy for oncological indications.	Oncoimmunology	2016	0.81
5	Current clinical trials testing the combination of immunotherapy with radiotherapy.	J Immunother Cancer	2016	0.81
6	Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies.	Front Oncol	2016	0.78
7	PD-1/PD-L1 blockades in non-small-cell lung cancer therapy.	Onco Targets Ther	2016	0.78
8	Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma.	Oncoimmunology	2016	0.77
9	Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.	Onco Targets Ther	2016	0.75